The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital

Annals of Clinical Microbiology and Antimicrobials

Volumn 16, Issue 1, 2017, Pages

  Ghaith, Doaa Mohammad ^a   Zafer, Mai Mahmoud ^b   Al Agamy, Mohamed Hamed ^c,d   Alyamani, Essam J ^e   Booq, Rayan Y ^e   Almoazzamy, Omar ^f  

^a CAIRO UNIVERSITY   (Egypt)

^b 4th Industrial Zone   (Egypt)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Al Azhar University   (Egypt)

^e KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^f Zagazig University   (Egypt)

Author keywords

OXA 23 like; A. baumannii; bla; MDR ; MLST

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; OXACILLINASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; BACTERIAL GENE; CROSS INFECTION; DRUG EFFECTS; EGYPT; EPIDEMIC; FEMALE; GENETICS; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; PROCEDURES; TERTIARY CARE CENTER; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EGYPT; FEMALE; GENES, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 85019145513     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-017-0208-y     Document Type: Article

References (23)

1. Ghaith DM, Hassan RM, Hasanin AM. Rapid identification of nosocomial A. baumannii isolated from a surgical intensive care unit in Egypt. Ann Saudi Med. 2015;36(5):440-4.
2. Hasanin A, Mukhtar A, El-Adawy A, Elazizi H, Lotfyn A, Nassar H, Ghaith D. Ventilator associated pneumonia caused by extensive-drug resistant Acinetobacter species: colistin is the remaining choice. Egypt J Anaesth. 2016. doi: 10.1016/j.egja.2016.03.004.
3. Helal S, El Anany M, Ghaith D, Rabeea S. The role of MDR- A. baumannii in orthopedic surgical site infections. Surg Infect. 2015. doi: 10.1089/sur.2014.187.
4. Poirel L, Nordmann P. Carbapenem resistance in A. baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826-36.
5. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem resistant A. baumannii. J Antimicrob Chemother. 2010;65:233-8.
6. OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44:2974-6.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. Document M100-S25. Wayne: CLSI; 2015.
8. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81.
9. Woodford N, Ellington M, Coelho J, Turton J, Ward M, Brown S, Amyes S, Livermore D. Multiplex PCR for genes encoding prevalent OXA Carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006. doi: 10.1016/j.ijantimicag.2006.01.004.
10. Alyamani EJ, Khiyami MA, Booq RY, Alnafjan BM, Altammami MA, Bahwerth FS. Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2015. doi: 10.1186/s12941-015-0098-9.
11. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013. doi: 10.1093/molbev/mst197.
12. Hasanin A, Eladawy A, Mohamed H, Salah Y, Lotfy A, Mostafa H, Ghaith D, Mukhtar A. Prevalence of extensively drug-resistant gram negative bacilli in surgical intensive care in Egypt. Pan Afr Med J. 2014. doi: 10.11604/pamj.2014.19.177.4307.
13. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant A. baumannii. Br Soc Antimicrob Chemother. 2010. doi: 10.1093/jac/dkp428.
14. Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing Enterobacteriaceae and A. baumannii in Mediterranean countries. Biomed Res Int. 2014. doi: 10.1155/2014/305784.
15. Hamouda A, Evans BA, Towner KJ. Amyes SBG. Characterization of epidemiologically unrelated A. baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of blaOXA-51-like genes. J Clin Microbiol. 2010;48:2476-83.
16. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter Baumannii. Emerg Infect Dis. 2009. doi: 10.3201/eid1601.090852.
17. Minandri F, D'Arezzo S, Antunes LCS, Pourcel C, Principe L, Petrosillo N, Visca P. Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter Baumannii strains belonging to international clonal lineage II. J Clin Microbiol. 2011. doi: 10.1128/jcm.05555-11.
18. Grosso F, Quinteira S, Peixe L. Understanding the dynamics of imipenem-resistant A. baumannii lineages within Portugal. Clin Microbiol Infect Dis. 2011. doi: 10.1111/j.1469-0691.2011.03469.x.
19. Rolain JM, Loucif L, Al-Maslamani M, Elmagboul E, Al-Ansari N, Taj-Aldeen S, et al. Emergence of multidrug-resistant A. baumannii producing OXA-23 carbapenemase in qatar. New Microbes New Infect. 2016. doi: 10.1016/j.nmni.2016.02.006.
20. El-Sayed MAEG, Amin MA, Tawakol WM, Loucif L, Bakour S, Rolain JM. High prevalence of blaNDM-1 carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical isolates in Egypt. Antimicrob Agents Chemother. 2015. doi: 10.1128/AAC.04412-14.
21. Al-Hassan L, El Mehallawy H, Amyes SG. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect. 2013. doi: 10.1111/1469-0691.12143.
22. Zowawi HM, Sartor AL, Sidjabat HE, Balkhy HH, Walsh TR, Al Johani SM, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council states: dominance of OXA-23-type producers. J Clin Microbiol. 2015. doi: 10.1128/JCM.02784-14.
23. Liu F, Zhu Y, Yi Y, Lu N, Zhu B, Hu Y. Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants. BMC Genomics. 2014. doi: 10.1186/1471-2164-15-1163.